Omnipaque Injection, Solution
FDA Recall NDC 0407-1401

Latest: Class II · Status: Ongoing · Initiated Mar 24, 2026 · 3 enforcement reports

Active & Historical Enforcement Reports

The FDA has identified 3 recorded enforcement report(s) associated with Omnipaque (NDC 0407-1401). A significant event, classified as Class II, was initiated on Mar 24, 2026 by Ge Healthcare Inc.. The reported reason for this action was: "Presence of particulate matter"

This recall is currently ONGOING. Healthcare providers and patients are advised to check their inventory immediately against the affected codes provided below.

Reported Recall Events

March 2026 Class II Recall: Presence of particulate matter

Recall Number
Class II Ongoing
Reason for Recall
Presence of particulate matter
Initiated
Mar 24, 2026
Reported
Apr 15, 2026
Quantity
306,810 vials

Recall Profile & Regulatory Data

Event ID
98656
Classification
Class II
Enforcement Status
Ongoing
Recalling Firm
GE Healthcare Ireland Limited
Voluntary / Mandated
Voluntary: Firm initiated
Distribution Pattern
U.S. Nationwide.
Product Description
GE Healthcare Omnipaque (iohexol) Injection, 350 mg/mL (64.7%), Rx Only, Distributed by: GE Healthcare Inc., Marlborough, MA 01752 USA, NDC 0407-1414-91.
Batch or Lot Expiration Information
Lot# 17333197; Exp. December 10, 2028
Lot# 17333198; Exp. November 17, 2028
Lot# 17396945; Exp. December 18, 2028
Lot# 17396948; Exp. December 22, 2028
Lot# 17396953; Exp. January 11, 2029
Lot# 17396956; Exp. January 9, 2029
Lot# 17423503; Exp. January 1, 2029
Lot# 17423525; Exp. January 3, 2029
Lot# 17426429; Exp. January 1, 2029
Lot# 17426440; Exp. January 4, 2029
Lot# 17431310; Exp. January 11, 2029
Affected Packages Involved in this Recall
0407-1401-52Omnipaque
0407-1411-10Omnipaque
0407-1411-20Omnipaque
0407-1412-10Omnipaque
0407-1412-20Omnipaque
0407-1412-50Omnipaque
0407-1412-29Omnipaque
0407-1412-30Omnipaque
0407-1412-60Omnipaque
0407-1412-33Omnipaque
0407-1412-27Omnipaque
0407-1412-49Omnipaque
0407-1412-34Omnipaque
0407-1412-28Omnipaque
0407-1412-35Omnipaque
0407-1413-11Omnipaque
0407-1413-10Omnipaque
0407-1413-59Omnipaque
0407-1413-30Omnipaque
0407-1413-50Omnipaque
0407-1413-51Omnipaque
0407-1413-61Omnipaque
0407-1413-95Omnipaque
0407-1413-98Omnipaque
0407-1413-62Omnipaque
0407-1413-99Omnipaque
0407-1413-60Omnipaque
0407-1413-63Omnipaque
0407-1413-91Omnipaque
0407-1413-53Omnipaque
0407-1413-90Omnipaque
0407-1413-65Omnipaque
0407-1413-92Omnipaque
0407-1413-66Omnipaque
0407-1413-93Omnipaque
0407-1413-96Omnipaque
0407-1413-69Omnipaque
0407-1414-21Omnipaque
0407-1414-50Omnipaque
0407-1414-51Omnipaque
0407-1414-52Omnipaque
0407-1414-89Omnipaque
0407-1414-20Omnipaque
0407-1414-90Omnipaque
0407-1414-22Omnipaque
0407-1414-53Omnipaque
0407-1414-60Omnipaque
0407-1414-91Omnipaque
0407-1414-76Omnipaque
0407-1414-03Omnipaque
0407-1414-23Omnipaque
0407-1414-93Omnipaque
0407-1414-04Omnipaque
0407-1414-94Omnipaque
0407-1414-24Omnipaque
0407-1414-80Omnipaque
0407-1414-95Omnipaque
0407-1415-09Omnipaque
0407-1416-12Omnipaque

March 2026 Class II Recall: Presence of particulate matter

Recall Number
Class II Ongoing
Reason for Recall
Presence of particulate matter
Initiated
Mar 24, 2026
Reported
Apr 15, 2026
Quantity
866,570 vials

Recall Profile & Regulatory Data

Event ID
98656
Classification
Class II
Enforcement Status
Ongoing
Recalling Firm
GE Healthcare Ireland Limited
Voluntary / Mandated
Voluntary: Firm initiated
Distribution Pattern
U.S. Nationwide.
Product Description
GE Healthcare Omnipaque (iohexol) Injection, 300 mg/mL (64.7%), Rx Only, Distributed by: GE Healthcare Inc., Marlborough, MA 01752 USA, NDC 0407-1413-63.
Batch or Lot Expiration Information
Lot# 17225029; Exp. September 3, 2028
Lot# 17265376; Exp. October 3, 2028
Lot# 17270885; Exp. September 10, 2028
Lot# 17292246; Exp. October 4, 2028
Lot# 17301805; Exp. October 18, 2028
Lot# 17301807; Exp. September 7, 2028
Lot# 17301810; Exp. October 20, 2028
Lot# 17304992; Exp. October 5, 2028
Lot# 17304993; Exp. October 19, 2028
Lot# 17304996; Exp. November 25, 2028
Lot# 17321225; Exp. September 8, 2028
Lot# 17333589; Exp. November 24, 2028
Lot# 17333611; Exp. November 26. 2028
Lot# 17333613; Exp. November 23. 2028
Lot# 17357000; Exp. December 5, 2028
Lot# 17366399; Exp. December 14, 2028
Lot# 17376486; Exp. December 14, 2028
Lot# 17404114; Exp. December 6, 2028
Affected Packages Involved in this Recall
0407-1401-52Omnipaque
0407-1411-10Omnipaque
0407-1411-20Omnipaque
0407-1412-10Omnipaque
0407-1412-20Omnipaque
0407-1412-50Omnipaque
0407-1412-29Omnipaque
0407-1412-30Omnipaque
0407-1412-60Omnipaque
0407-1412-33Omnipaque
0407-1412-27Omnipaque
0407-1412-49Omnipaque
0407-1412-34Omnipaque
0407-1412-28Omnipaque
0407-1412-35Omnipaque
0407-1413-11Omnipaque
0407-1413-10Omnipaque
0407-1413-59Omnipaque
0407-1413-30Omnipaque
0407-1413-50Omnipaque
0407-1413-51Omnipaque
0407-1413-61Omnipaque
0407-1413-95Omnipaque
0407-1413-98Omnipaque
0407-1413-62Omnipaque
0407-1413-99Omnipaque
0407-1413-60Omnipaque
0407-1413-63Omnipaque
0407-1413-91Omnipaque
0407-1413-53Omnipaque
0407-1413-90Omnipaque
0407-1413-65Omnipaque
0407-1413-92Omnipaque
0407-1413-66Omnipaque
0407-1413-93Omnipaque
0407-1413-96Omnipaque
0407-1413-69Omnipaque
0407-1414-21Omnipaque
0407-1414-50Omnipaque
0407-1414-51Omnipaque
0407-1414-52Omnipaque
0407-1414-89Omnipaque
0407-1414-20Omnipaque
0407-1414-90Omnipaque
0407-1414-22Omnipaque
0407-1414-53Omnipaque
0407-1414-60Omnipaque
0407-1414-91Omnipaque
0407-1414-76Omnipaque
0407-1414-03Omnipaque
0407-1414-23Omnipaque
0407-1414-93Omnipaque
0407-1414-04Omnipaque
0407-1414-94Omnipaque
0407-1414-24Omnipaque
0407-1414-80Omnipaque
0407-1414-95Omnipaque
0407-1415-09Omnipaque
0407-1416-12Omnipaque

October 2018 Class II Recall: Defective Container

Recall Number
Class II Terminated
Reason for Recall
Defective Container: vial defect was identified that could potentially impact the container closure and result in a lack of sterility assurance and/or the potential for glass particles.
Initiated
Oct 29, 2018
Reported
Dec 26, 2018
Quantity
1092 cartons

Recall Profile & Regulatory Data

Event ID
81691
Classification
Class II
Enforcement Status
Terminated
Recalling Firm
GE Healthcare Inc. Life Sciences
Voluntary / Mandated
Voluntary: Firm initiated
Distribution Pattern
TN
Termination Date
Oct 30, 2023
Product Description
Omnipaque (iohexol) Injection, 180mgI/mL, 20 mL Single-Dose Vial, packaged in 10 x 20 mL Vials per carton, Rx only, Distributed by GE Healthcare Inc., Marlborough, MA 01752 U.S.A.; Manufactured by GE Healthcare AS, Oslo, Norway; NDC 0407-1411-20.
Batch or Lot Expiration Information
Lot# : 14301544, Exp 21Sep21
Affected Packages Involved in this Recall
0407-1401-52Omnipaque
0407-1411-10Omnipaque
0407-1411-20Omnipaque
0407-1412-10Omnipaque
0407-1412-20Omnipaque
0407-1412-50Omnipaque
0407-1412-29Omnipaque
0407-1412-30Omnipaque
0407-1412-60Omnipaque
0407-1412-33Omnipaque
0407-1412-27Omnipaque
0407-1412-49Omnipaque
0407-1412-34Omnipaque
0407-1412-28Omnipaque
0407-1412-35Omnipaque
0407-1413-11Omnipaque
0407-1413-10Omnipaque
0407-1413-59Omnipaque
0407-1413-30Omnipaque
0407-1413-50Omnipaque
0407-1413-51Omnipaque
0407-1413-61Omnipaque
0407-1413-95Omnipaque
0407-1413-98Omnipaque
0407-1413-62Omnipaque
0407-1413-99Omnipaque
0407-1413-60Omnipaque
0407-1413-63Omnipaque
0407-1413-91Omnipaque
0407-1413-53Omnipaque
0407-1413-90Omnipaque
0407-1413-65Omnipaque
0407-1413-92Omnipaque
0407-1413-66Omnipaque
0407-1413-93Omnipaque
0407-1413-96Omnipaque
0407-1413-69Omnipaque
0407-1414-21Omnipaque
0407-1414-50Omnipaque
0407-1414-51Omnipaque
0407-1414-52Omnipaque
0407-1414-89Omnipaque
0407-1414-20Omnipaque
0407-1414-90Omnipaque
0407-1414-22Omnipaque
0407-1414-53Omnipaque
0407-1414-60Omnipaque
0407-1414-91Omnipaque
0407-1414-76Omnipaque
0407-1414-03Omnipaque
0407-1414-23Omnipaque
0407-1414-93Omnipaque
0407-1414-04Omnipaque
0407-1414-94Omnipaque
0407-1414-24Omnipaque
0407-1414-80Omnipaque
0407-1414-95Omnipaque
0407-1415-09Omnipaque
0407-1416-12Omnipaque

About FDA Recall Enforcement Reports

FDA recall data documents classified recall actions associated with a product. Most recalls are limited to specific lots, batches, or package configurations rather than every unit of a drug.

If a recall is listed for an NDC, review the affected lot information and package details carefully. Patients and healthcare professionals should confirm whether a specific product in hand matches the lot or package information before assuming it is affected.